Usefulness of The C‐Reactive Protein/Albumin Ratio for Predicting No‐Reflow in <scp>ST</scp>‐elevation myocardial infarction treated with primary percutaneous coronary intervention

Abstract

No-reflow can be predicted by systemic inflammation markers including WBC count, NLR and CAR measured from the blood sample obtained on admission. CAR has a higher clinical value than CRP, albumin level, WBC count and NLR in NR prediction.